- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
For appendix CT scan, bring a tape measure
Imagers know that you can skip the contrast in heavier patients undergoing CT scans for suspected appendicitis, but just how heavy is heavy enough?
Imagers know that you can skip the contrast in heavier patients undergoing CT scans for suspected appendicitis, but just how heavy is heavy enough?
Researchers at McMaster University in Ontario, Canada, have developed one indicator: body girth. In a scientific paper presented Tuesday, they reported that in patients with an abdominal girth of 105 cm or more, it is safe to skip the contrast and still get a good image of the appendix.
In CT scans, abdominal fat helps visualize the appendix. Without the fat, contrast is needed to bring out the organ.
Investigators retrospectively evaluated unenhanced helical CT scans of 108 patients to determine whether a normal appendix could be identified by both a radiology resident and a staff abdominal radiologist. They developed a computer program to estimate abdominal girth at the level of the iliac crests, said Dr. Kelly Ainsworth, the presenter and a fourth-year radiology resident.
The appendix was seen in 74 patients and not seen in 34. A statistical analysis determined that abdominal girth averaged 19.42 cm larger in those patients in whom the appendix was visible (p <0.001) than in those in which it was not visible. An ROC analysis demonstrated that for those whose abdominal girth is greater than 105 cm (p <0.001), an unenhanced CT scan adequately identifies the appendix.
Besides reducing the risk attendant on contrast injection, an unenhanced scan also reduces the time needed to administer and wait for the contrast. In slim patients, ultrasound or contrast CT is necessary, Ainsworth said.
Ainsworth was asked about other potential measures, such as body mass index. She said the facility is continuing its research into other indicators, including visceral fat.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
